Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Louis

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
BMC Cancer|October 9, 2004
CD155/PVR plays a key role in cell motility during tumor cell invasion and migrationKevin E Sloan, Brenda K Eustace, Jean K Stewart, et al.
Brain Pathology (Zurich, Switzerland)|October 27, 2025
AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for WHO CNS5 adult-type diffuse gliomasVani Santosh, Chitra Sarkar, Shilpa Rao, et al.
Acta Neuropathologica|January 27, 2018
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)David N Louis, Pieter Wesseling, Werner Paulus, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Genes & Development|January 11, 2007
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastomaAlexander H Stegh, Hyunggee Kim, Robert M Bachoo, et al.
Journal of Neuropathology and Experimental Neurology|June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor MicroenvironmentFares Nigim, Jill Cavanaugh, Anoop P Patel, et al.
Comparative Medicine|July 16, 2004
Mouse models of human cancers (part 3)Alexander D Borowsky, Robert J Munn, Jose J Galvez, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Plos One|April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implicationsDora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
BMC Cancer|October 9, 2004
CD155/PVR plays a key role in cell motility during tumor cell invasion and migrationKevin E Sloan, Brenda K Eustace, Jean K Stewart, et al.
Brain Pathology (Zurich, Switzerland)|October 27, 2025
AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for WHO CNS5 adult-type diffuse gliomasVani Santosh, Chitra Sarkar, Shilpa Rao, et al.
Acta Neuropathologica|January 27, 2018
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)David N Louis, Pieter Wesseling, Werner Paulus, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Genes & Development|January 11, 2007
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastomaAlexander H Stegh, Hyunggee Kim, Robert M Bachoo, et al.
Journal of Neuropathology and Experimental Neurology|June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor MicroenvironmentFares Nigim, Jill Cavanaugh, Anoop P Patel, et al.
Comparative Medicine|July 16, 2004
Mouse models of human cancers (part 3)Alexander D Borowsky, Robert J Munn, Jose J Galvez, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Plos One|April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implicationsDora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
Pageof 22